BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2915872)

  • 21. Management of thromboembolic disease associated with pregnancy.
    Evans W; Laifer SA; McNanley TJ; Ruzycky A
    J Matern Fetal Med; 1997; 6(1):21-7. PubMed ID: 9029380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Subcutaneous heparin during the first trimesters of pregnancy in women with prosthetic heart valves].
    Parra C; Kauffmann R; Chateau B; Cabrera E
    Rev Med Chil; 1999 Dec; 127(12):1475-9. PubMed ID: 10835755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acquired protein C deficiency in ulcerative colitis. The cause of thromboembolic complications].
    Korsten S; Reis HE
    Dtsch Med Wochenschr; 1992 Mar; 117(11):419-24. PubMed ID: 1347501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombosis therapy and the prophylaxis of thrombosis recurrences in obstetrics].
    Voigt T; Voigt H; Wegner H; Scheel H
    Z Gesamte Inn Med; 1981 Jun; 36(12):418-21. PubMed ID: 7303769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balancing the risk of recurrent thromboembolism and pre-existing osteoporosis in pregnancy.
    Kyei-Mensah A; Machin SJ; Jacobs HS
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):77-81. PubMed ID: 7742521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboprophylaxis with low molecular mass heparin, 'Fragmin' (dalteparin), during pregnancy--a longitudinal safety study.
    Blombäck M; Bremme K; Hellgren M; Siegbahn A; Lindberg H
    Blood Coagul Fibrinolysis; 1998 Jan; 9(1):1-9. PubMed ID: 9607113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Incidence of thromboembolic complications in cesarean sections and heparin prophylaxis].
    Corosu R; Vizzaccaro F; Moretti S
    Minerva Ginecol; 1999 May; 51(5):173-6. PubMed ID: 10431525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversies in thromboembolic disease during pregnancy: a critical review.
    Barbour LA; Pickard J
    Obstet Gynecol; 1995 Oct; 86(4 Pt 1):621-33. PubMed ID: 7675391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral venous thrombosis during pregnancy in the setting of type I antithrombin deficiency: case report and literature review.
    Sharpe CJ; Crowther MA; Webert KE; Donnery C
    Transfus Med Rev; 2011 Jan; 25(1):61-5. PubMed ID: 21134627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation during pregnancy.
    Pabinger I; Grafenhofer H
    Semin Thromb Hemost; 2003 Dec; 29(6):633-8. PubMed ID: 14719179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
    James AH; Brancazio LR; Ortel TL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cutaneous necrosis at the initiation of antivitamin K treatment disclosing hereditary protein C deficiency].
    Piffoux M; Tcherakian F; Tcherakian S; Horellou MH
    Rev Pneumol Clin; 1990; 46(3):125-7. PubMed ID: 2237146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thromboembolism and ovarian hyperstimulation].
    Hocke C; Guyon F; Dulucq MC; Grenier N; Papaxanthos A; Leng JJ
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(7):691-6. PubMed ID: 8568175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The perioperative management of protein S deficiency in total hip arthroplasty.
    Cecil ML; Fenton PJ; Jackson WT
    Clin Orthop Relat Res; 1994 Jun; (303):170-2. PubMed ID: 8194228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pregnancy and delivery in type II hereditary antithrombin deficient patients].
    Hajsmanová Z
    Cas Lek Cesk; 2008; 147(10):535-7. PubMed ID: 19177736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Factor V Leiden mutation. Successful outcome of a pregnancy after heparin therapy].
    Mazzarella CR; Del Bianco A; Pietropaolo F
    Minerva Ginecol; 2003 Feb; 55(1):81-5. PubMed ID: 12598848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of repeated fetal death in utero with heparin therapy].
    Dellenbach P; Baulu M; Hsiung R; Spielmann A; Nisand I
    Agressologie; 1983 Nov; 24(10):501-3. PubMed ID: 6670677
    [No Abstract]   [Full Text] [Related]  

  • 38. Replacement therapy with a purified protein C concentrate during initiation of oral anticoagulation in severe protein C congenital deficiency.
    De Stefano V; Mastrangelo S; Schwarz HP; Pola P; Flore R; Bizzi B; Leone G
    Thromb Haemost; 1993 Aug; 70(2):247-9. PubMed ID: 8236128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contraceptive agents and risk of thrombosis].
    Maurer-Major E; Keller PJ
    Praxis (Bern 1994); 1997 Oct; 86(40):1543-8. PubMed ID: 9417570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Protein S and pregnancy].
    Dunjić R; Elezović I; Rakić S; Miković Z; Loncar-Stevanović H
    Srp Arh Celok Lek; 2002; 130(1-2):36-7. PubMed ID: 12073286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.